Jim Simons’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Jim Simons’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,500	Closed	-$80K	–	4543
2022 Q2	$80K	Buy	18,500 +4,300	+30%	+$24.4K	﹤0.01%	3901
2022 Q1	$165K	Sell	14,200 -10,500	-43%	-$125K	﹤0.01%	3695
2021 Q4	$451K	Sell	24,700 -87,600	-78%	-$1.11M	﹤0.01%	3124
2021 Q3	$1.33M	Buy	+112,300	New	+$1.64M	﹤0.01%	2388
2021 Q1	–	Sell	-30,639	Closed	-$577K	–	3844
2020 Q4	$577K	Sell	30,639 -14,861	-33%	-$320K	﹤0.01%	2757
2020 Q3	$961K	Buy	45,500 +10,800	+31%	+$253K	﹤0.01%	2542
2020 Q2	$1M	Buy	+34,700	New	+$1.05M	﹤0.01%	2536

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jim Simons's OYST Position: Q3 2022 in Review

Jim Simons sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 18,500 shares — an estimated $80K sold.

Jim Simons first reported a position in OYST in Q2 2020 and held it in 7 quarters. The position peaked at $1.33M in Q3 2021. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

Jim Simons reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Jim Simons sold 18,500 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $80K.
Jim Simons first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Jim Simons's Oyster Point Pharma, Inc. Common Stock position peaked at $1.33M in Q3 2021.
60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.